Evidence-based GLP-1 RA clinical considerations and their relative attributes
An in-depth look at the GLP-1 RA class and how they compare with respect to the clinical considerations of people living with type 2 diabetes
This is a promotional symposium sponsored by Lilly. Please note this session is not eligible for accreditation.
Intended for UK Healthcare Professionals.
Relevant prescribing information and adverse event reporting can be found within the symposium presentation and on the Lilly stand.